A 10-year PFS simulation model based on the ECHELON-1 trial in Hodgkin lymphoma

Brentuximab vedotin in treatment naïve cHL patients: a 5-year update of the ECHELON-1 trialПодробнее

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin LymphomaПодробнее

ECHELON-1 trial updates: overall survival dataПодробнее

Overview of ECHELON-1 Study for Hodgkin LymphomaПодробнее

ECHELON 1 Improves survival | Does the trial add up? | V Prasad investigates for Plenary SessionПодробнее

Results of ECHELON-1 study for Hodgkin LymphomaПодробнее

5-year follow-up of ECHELON-1: brentuximab plus AVD versus ABVD in Hodgkin lymphomaПодробнее

Hodgkin lymphoma updates in the UK: ECHELON-1Подробнее

ENM2020 - W33T1 - Mechanistic Models - cПодробнее

LABORATORY 1: TRAFFIC LIGHTS SYSTEM SIMULATION (EDUCATIONAL PURPOSE ONLY, INDTCH 5, FST 3-I)Подробнее

Novel therapies for patients with MCL after failed response to BTK inhibitorsПодробнее

Real time fracture simulationПодробнее

20 Petaflop Simulation of ProteinsПодробнее

HS 201: REAL-TIME AND STOCHASTIC HYBRID SIMULATIONПодробнее

Fluid and solid mechanics via the unified continuum mechanics modelПодробнее

Wavefield Simulation and 3D Object Reconstruction on the Giga-Pixel ScaleПодробнее